^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CD20 expression

    i
    Other names: CD20, MS4A1, Membrane Spanning 4-Domains A1, Membrane-Spanning 4-Domains, Subfamily A, Member 1, Leukocyte Surface Antigen Leu-16, B-Lymphocyte Antigen CD20, CD20 Antigen, Membrane-Spanning 4-Domains Subfamily A Member 1, B-Lymphocyte Cell-Surface Antigen B1, B-Lymphocyte Surface Antigen B1, CD20 Receptor, LEU-16, CVID5, MS4A2
    Entrez ID:
    494216
    Related biomarkers:
    Expression
    Others
    over1year
    Pathology Board Review Which of the following lymphomas expresses CD20? (@AaronGoodman33)
    Review
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 expression
    over1year
    People like CD questions! Which of the following lymphomas is most likely to express CD20? (@AaronGoodman33)
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 expression
    almost2years
    Lymphocytosis patient with following flow profile: Flow cytometric analysis shows that the cells express CD5, CD19, CD20, and CD23. CD79b and FMC7 are negative. CD10 and Bcl-6 are also negative. 1.CLL, 2 HCL 3 FL 4MCL 5 MZL? (@wangyub)
    Clinical
    |
    CD20 (Membrane Spanning 4-Domains A1) • CD19 (CD19 Molecule) • BCL6 (B-cell CLL/lymphoma 6) • CD79B (CD79b Molecule) • CD5 (CD5 Molecule) • MME (Membrane Metalloendopeptidase) • FCER2 (Fc Fragment Of IgE Receptor II)
    |
    CD20 expression • CD19 expression
    over2years
    @AaronGoodman33 48yo lady w EGD showing gastric ulcer but incidental duodenal mucosal nodule bx follicular NHL of duodenal type; expressed CD20, coexpress CD10, BCL-2. Ki-67 was pos at less than 5%. CT CAP negative; bone marrow bx neg. Do you/followers think needs treatment? (@DocMCotant)
    BCL2 (B-cell CLL/lymphoma 2) • CD20 (Membrane Spanning 4-Domains A1) • MME (Membrane Metalloendopeptidase)
    |
    BCL2 expression • CD20 expression
    over2years
    New #JITC article: Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML @Daver_Leukemia https://t.co/2kuvNrpyxY (@jitcancer)
    CD200 (CD200 Molecule)
    |
    CD20 expression • CD20 overexpression • CD200 expression
    almost3years
    Fascinating study in patients with BRAF mutant hairy cell leukemia. BRAF inhibitors have known efficacy. Here, they used defined course of BRAF inhibitor+rituximab (they express CD20). Impressive CR rate and relapse-free survival. many caveats, but cool. https://t.co/ma9I92u2zb (@RielyMD)
    Clinical
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    BRAF mutation • CD20 expression
    |
    Rituxan (rituximab)